Banco Bilbao Vizcaya Argentaria S.A. Purchases 15,600 Shares of Danaher Corporation $DHR

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. increased its shares in Danaher Corporation by 51.1%, owning a total of 46,116 shares valued at $9,416,000 as of the most recent SEC filing.
• Several institutional investors, including Vanguard Group Inc. and Bank of New York Mellon Corp, have also raised their stakes in Danaher, indicating strong institutional interest in the company.
• Analysts have mixed views on Danaher's stock price, with target prices ranging from $240 to $248, and a consensus rating of "Moderate Buy" based on 17 buy ratings and 3 hold ratings.

Banco Bilbao Vizcaya Argentaria S.A. increased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 51.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,116 shares of the conglomerate's stock after acquiring an additional 15,600 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Danaher were worth $9,416,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Danaher by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate's stock worth $12,296,123,000 after buying an additional 230,966 shares during the period. Bank of New York Mellon Corp raised its holdings in Danaher by 2.3% during the 1st quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate's stock worth $1,800,614,000 after buying an additional 194,466 shares during the period. Northern Trust Corp raised its holdings in Danaher by 14.3% during the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock worth $1,821,477,000 after buying an additional 992,594 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Danaher by 11.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,677,032 shares of the conglomerate's stock worth $1,303,163,000 after buying an additional 579,046 shares during the period. Finally, Invesco Ltd. raised its holdings in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares during the period. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several brokerages have commented on DHR. The Goldman Sachs Group dropped their target price on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Leerink Partners raised their target price on shares of Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. TD Cowen raised their target price on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a report on Wednesday, April 23rd. HSBC lowered their price objective on shares of Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Finally, Argus lowered their price objective on shares of Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Price Performance

NYSE DHR opened at $212.2350 on Wednesday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The company has a market capitalization of $151.97 billion, a PE ratio of 45.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.73. The firm's 50 day moving average is $200.33 and its 200-day moving average is $199.54.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.